These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 22405559

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Engineering of Genetically Arrested Parasites (GAPs) For a Precision Malaria Vaccine.
    Kreutzfeld O, Müller K, Matuschewski K.
    Front Cell Infect Microbiol; 2017; 7():198. PubMed ID: 28620583
    [Abstract] [Full Text] [Related]

  • 24. Strain-specific immunity induced by immunization with pre-erythrocytic stages of Plasmodium chabaudi.
    Culleton RL, Inoue M, Reece SE, Cheesman S, Carter R.
    Parasite Immunol; 2011 Jan; 33(1):73-8. PubMed ID: 21189655
    [Abstract] [Full Text] [Related]

  • 25. Reduced Plasmodium berghei sporozoite liver load associates with low protective efficacy after intradermal immunization.
    Nganou-Makamdop K, Ploemen I, Behet M, Van Gemert GJ, Hermsen C, Roestenberg M, Sauerwein RW.
    Parasite Immunol; 2012 Dec; 34(12):562-9. PubMed ID: 23171040
    [Abstract] [Full Text] [Related]

  • 26. Frequent inoculations with radiation attenuated sporozoite is essential for inducing sterile protection that correlates with a threshold level of Plasmodia liver-stage specific CD8+ T cells.
    Patel H, Yadav N, Parmar R, Patel S, Singh AP, Shrivastava N, Dalai SK.
    Cell Immunol; 2017 Jul; 317():48-54. PubMed ID: 28499490
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice.
    Aly AS, Downie MJ, Mamoun CB, Kappe SH.
    Cell Microbiol; 2010 Jul; 12(7):930-8. PubMed ID: 20088947
    [Abstract] [Full Text] [Related]

  • 29. Plasmodium berghei sporozoite challenge of vaccinated BALB/c mice leads to the induction of humoral immunity and improved function of CD8(+) memory T cells.
    Tartz S, Deschermeier C, Retzlaff S, Heussler V, Sebo P, Fleischer B, Jacobs T.
    Eur J Immunol; 2013 Mar; 43(3):693-704. PubMed ID: 23229763
    [Abstract] [Full Text] [Related]

  • 30. Genetic engineering of attenuated malaria parasites for vaccination.
    Khan SM, Janse CJ, Kappe SH, Mikolajczak SA.
    Curr Opin Biotechnol; 2012 Dec; 23(6):908-16. PubMed ID: 22560204
    [Abstract] [Full Text] [Related]

  • 31. T cells as mediators of protective immunity against liver stages of Plasmodium.
    Tsuji M, Zavala F.
    Trends Parasitol; 2003 Feb; 19(2):88-93. PubMed ID: 12586477
    [Abstract] [Full Text] [Related]

  • 32. Cellular and humoral immune effector mechanisms required for sterile protection against sporozoite challenge induced with the novel malaria vaccine candidate CelTOS.
    Bergmann-Leitner ES, Legler PM, Savranskaya T, Ockenhouse CF, Angov E.
    Vaccine; 2011 Aug 11; 29(35):5940-9. PubMed ID: 21722682
    [Abstract] [Full Text] [Related]

  • 33. Mechanisms of stage-transcending protection following immunization of mice with late liver stage-arresting genetically attenuated malaria parasites.
    Sack BK, Keitany GJ, Vaughan AM, Miller JL, Wang R, Kappe SH.
    PLoS Pathog; 2015 May 11; 11(5):e1004855. PubMed ID: 25974076
    [Abstract] [Full Text] [Related]

  • 34. Pre-erythrocytic stage malaria vaccines: time for a change in path.
    Druilhe P, Barnwell JW.
    Curr Opin Microbiol; 2007 Aug 11; 10(4):371-8. PubMed ID: 17709281
    [Abstract] [Full Text] [Related]

  • 35. Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials.
    Nardin E, Zavala F, Nussenzweig V, Nussenzweig RS.
    Parassitologia; 1999 Sep 11; 41(1-3):397-402. PubMed ID: 10697892
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Vaccination using radiation- or genetically attenuated live sporozoites.
    Vaughan AM, Kappe SH.
    Methods Mol Biol; 2013 Sep 11; 923():549-66. PubMed ID: 22990804
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. The Development of Whole Sporozoite Vaccines for Plasmodium falciparum Malaria.
    Itsara LS, Zhou Y, Do J, Grieser AM, Vaughan AM, Ghosh AK.
    Front Immunol; 2018 Sep 11; 9():2748. PubMed ID: 30619241
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.